Sign in →

Test ID LDPU Limited Drug Profile, 3 Drug Classes, Immunoassay, Random, Urine


Ordering Guidance


The test does not screen for drug classes other than those listed above.



Specimen Required


Only orderable as part of profile. For more information see CSMHU / Controlled Substance Monitoring Hybrid Drug Panel, 20 Drug Classes, High-Resolution Mass Spectrometry and Immunoassay Screen, Random, Urine.

 

Container/Tube: Plastic, 10 mL tube

Specimen Volume: 2 mL

Collection Instructions:

1. Collect a random urine specimen.

2. No preservative


Secondary ID

615289

Useful For

Detecting drug use involving barbiturates, cocaine, and tetrahydrocannabinol

 

This test is not intended for use in employment-related testing.

Testing Algorithm

Testing begins with screening tests for drugs of abuse including barbiturates, cocaine, and tetrahydrocannabinol.

 

Positive results can be confirmed and quantitated by definitive methods (gas chromatography-mass spectrometry for barbiturates, cocaine and metabolites, and tetrahydrocannabinol metabolite) at an additional charge.

Method Name

Only orderable as part of profile. For more information see CSMHU / Controlled Substance Monitoring Hybrid Drug Panel, 20 Drug Classes, High-Resolution Mass Spectrometry and Immunoassay Screen, Random, Urine.

 

Screened by Immunoassay

Reporting Name

Limited Drug Panel, 3, IA, U

Specimen Type

Urine

Specimen Minimum Volume

0.5 mL

Specimen Stability Information

Specimen Type Temperature Time
Urine Refrigerated (preferred) 14 days
  Frozen  14 days
  Ambient  72 hours

Clinical Information

This test uses the simple screening technique that involves immunologic testing for drugs by class.

 

All positive immunoassay screening results can be confirmed by gas chromatography-mass spectrometry (GC-MS) and quantitated if applicable.

 

This assay was designed to test for the following:

-Barbiturates

-Cocaine

-Tetrahydrocannabinol

Reference Values

Only orderable as part of profile. For more information see CSMHU / Controlled Substance Monitoring Hybrid Drug Panel, 20 Drug Classes, High-Resolution Mass Spectrometry and Immunoassay Screen, Random, Urine.

 

Negative

Screening cutoff concentrations:

Barbiturates: 200 ng/mL

Cocaine (benzoylecgonine-cocaine metabolite): 150 ng/mL

Tetrahydrocannabinol carboxylic acid: 50 ng/mL

 

This report is intended for use in clinical monitoring or management of patients. It is not intended for use in employment-related testing.

Cautions

No significant cautionary statements

Day(s) Performed

Monday through Friday

Report Available

Same day/1 to 2 days

Performing Laboratory

Mayo Clinic Laboratories in Rochester

Test Classification

This test has been cleared, approved, or is exempt by the US Food and Drug Administration and is used per manufacturer's instructions. Performance characteristics were verified by Mayo Clinic in a manner consistent with CLIA requirements.

CPT Code Information

80307

NY State Approved

Yes